AME Company for Medical Supplies provides medical devices and equipment, including hyaluronic acid dermal fillers, medical laser systems, autologous concentration equipment, and other medical devices. In 2008, the company became the official Authorized Representative for TEOXANE & DEKA, market leaders in their category. In 2017, AME became an authorized representative for Magellan, GMV, NOVAVISION & Mesojet; in 2020 for KORUST, a Korean Ultrasound Technology Company; and in 2021 for MINT, NABOTA & EUROMI.
The company is headquartered in Jeddah, Makkah, with 51-200 employees, and operates as a public company. The company's current capital is SAR 70 million, divided into seven million shares with a nominal value of SAR 10 per share. AME was transformed to a Saudi joint stock company in June 2021 and began trading on Nomu – Parallel Market on January 18, 2022, as a direct listing.
As of the latest data, AME Company has 68 employees. In 2025, the company reported that profit and revenue for the first half grew year over year.
Facts compiled by Executive Moves from publicly available news and press releases on 4 August 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you on the AME Company for Medical Supplies team?
This is a Light company page, auto-generated from public news coverage. Claim it to verify the company description, add logo and links, and control how your organisation is represented on Executive Moves.
Claim this company →
